New Discoveries and Honors in Cancer Research

Read the latest cancer research and recognition from the members of the Damon Runyon scientific circle.
June 7, 2011
Promising target for treatment of non-small cell lung cancer

Nathanael S. Gray, PhD (Damon Runyon-Rachleff Innovator ‘08-‘10), Matthew Meyerson, MD, PhD (Damon Runyon Fellow ‘95-‘98) and colleagues at Dana-Farber Cancer Institute, Boston, reported that the gene FGFR1 is amplified in 21% of squamous cell lung cancers. In cell lines, inhibition of FGFR blocked cell growth. These findings suggest that FGFR may be a promising therapeutic target for these lung cancers. The report was published in the journal PLoS ONE.